Volume: 11 Issue: 3
Year: 2023, Page: 1-3, Doi: https://doi.org/10.47799/pimr.1103.01
Received: Nov. 30, 2023 Accepted: Dec. 12, 2023 Published: Dec. 12, 2023
Keywords:
Berg, K . 1963. A new serum type system in man-the Lp system. Acta Pathol Microbiol Scand 59(3):369–82.
Tsimikas, S . 2017. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol 69(6):692–711.
Nordestgaard, B G, Chapman, M J & Ray, K . 2010. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31(23):2844–53.
Burgess, Stephen, Ference, Brian A, Staley, James R, Freitag, Daniel F, Mason, Amy M, Nielsen, Sune F, Willeit, Peter, Young, Robin, Surendran, Praveen & Karthikeyan, Savita . 2018. Association of LPA variants with risk of coronary disease and the implications for lipoprotein (a)-lowering therapies: a Mendelian randomization analysis. JAMA cardiology 3(7):619–627.
Landray, M J, Haynes, R & Hopewell, J C . 2014. Effects of extended-release niacin with laropiprant in high risk patients. N Engl J Med 317(3):203–215.
Boden, W E, Probstfield, J L & Anderson, T . 2011. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 365(24):2255–67.
Cannon, C P, Shah, S & Dansky, H M . 2010. Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl Med 363:2406–2421.
Viney, N J, Van Capelleveen, J C & Geary, R S . 2016. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. Lancet 388:2239–53.
Iyengar, Shamanna S, Puri, Raman & Narasingan, SN . 2016. Lipid association of India expert consensus statement on management of dyslipidemia in Indians 2016: Part 1-executive summary. Journal of Clinical and Preventive Cardiology 5(2):51–61.
©2023 K Ravinder Reddy et al. This is an open-access journal, and articles are distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
Reddy KR, Gowtham S, Reddy Challa T. The Unmet Residual Factor For Coronary Artery Disease (CAD):Lipoprotein(a). Perspectives in Medical Research. 2023;11(3):1-3 DOI: 10.47799/pimr.1103.01